If the cost of your generic prescription drug has risen, it may be due to a lack of competition among drug manufacturers, according to a University of Florida College of Pharmacy study. More than four ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/07fbd3/generic_growth_str) has announced the addition of the "Generic Growth ...
Though generic drugs represent more than 90% of dispensed prescriptions, generic drug manufacturers continue to face pressure from drug distributors, pharmacy benefit managers, and competitors. But ...
WASHINGTON – U.S. Sen. Jeanne Shaheen (D-NH) and Susan Collins (R-ME), co-chairs of the Senate Diabetes Caucus, along with Senators Michael Bennet (D-CO), Marco Rubio (R-FL), Tammy Baldwin (D-WI) and ...
The generic sterile injectables market accounted for $ 68.7 billion in 2019 and is estimated to be $196.2 billion by 2029 and is anticipated to register a CAGR of 11.2%, per a report from Prophecy ...
Ned Sharpless, MD, the FDA’s acting commissioner, said Oct.16 that the agency broke its record for most generic drug approvals this year. The agency approved 1,171 generic drugs in the 2019 fiscal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback